Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus
- 1 November 2005
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 193 (5) , 1691-1697
- https://doi.org/10.1016/j.ajog.2005.04.015
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Free insulin-like growth factors – measurements and relationships to growth hormone secretion and glucose homeostasisGrowth Hormone & IGF Research, 2004
- Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational studyThe Lancet, 2002
- Tumor necrosis factor system in insulin resistance in gestational diabetesDiabetes Research and Clinical Practice, 2002
- Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2002
- Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populationsDiabetologia, 2001
- Insulin-Like Growth Factor Binding Proteins: New Proteins, New FunctionsHormone Research in Paediatrics, 1999
- Pronounced Insulin Resistance and Inadequate β-cell Secretion Characterize Lean Gestational Diabetes During and After PregnancyDiabetes Care, 1997
- Gestational Diabetes: Should It Be Added to the Syndrome of Insulin Resistance?Diabetes Care, 1997
- Could abnormalities in insulin-like growth factors and their binding proteins during pregnancy result in gestational diabetes?Journal of Endocrinology, 1995
- Growth Hormone-Binding Protein in Plasma Is Inversely Correlated to Placental Lactogen and Augmented with Increasing Body Mass Index in Healthy Pregnant Women and Women with Gestational Diabetes mellitusGynecologic and Obstetric Investigation, 1994